99 related articles for article (PubMed ID: 31011505)
1. Structure-Activity Relationship of NF023 Derivatives Binding to XIAP-BIR1.
Sorrentino L; Cossu F; Milani M; Malkoc B; Huang WC; Tsay SC; Ru Hwu J; Mastrangelo E
ChemistryOpen; 2019 Apr; 8(4):476-482. PubMed ID: 31011505
[TBL] [Abstract][Full Text] [Related]
2. NF023 binding to XIAP-BIR1: searching drugs for regulation of the NF-κB pathway.
Cossu F; Milani M; Grassi S; Malvezzi F; Corti A; Bolognesi M; Mastrangelo E
Proteins; 2015 Apr; 83(4):612-20. PubMed ID: 25619915
[TBL] [Abstract][Full Text] [Related]
3. XIAP induces NF-kappaB activation via the BIR1/TAB1 interaction and BIR1 dimerization.
Lu M; Lin SC; Huang Y; Kang YJ; Rich R; Lo YC; Myszka D; Han J; Wu H
Mol Cell; 2007 Jun; 26(5):689-702. PubMed ID: 17560374
[TBL] [Abstract][Full Text] [Related]
4. Computational and Experimental Characterization of NF023, A Candidate Anticancer Compound Inhibiting cIAP2/TRAF2 Assembly.
Cossu F; Sorrentino L; Fagnani E; Zaffaroni M; Milani M; Giorgino T; Mastrangelo E
J Chem Inf Model; 2020 Oct; 60(10):5036-5044. PubMed ID: 32820924
[TBL] [Abstract][Full Text] [Related]
5. Integrity of XIAP is essential for effective activity recovery of apoptosome and its downstream caspases by Smac/Diablo.
Attaran-Bandarabadi F; Abhari BA; Neishabouri SH; Davoodi J
Int J Biol Macromol; 2017 Aug; 101():283-289. PubMed ID: 28322955
[TBL] [Abstract][Full Text] [Related]
6. Crystal structure of the BIR1 domain of XIAP in two crystal forms.
Lin SC; Huang Y; Lo YC; Lu M; Wu H
J Mol Biol; 2007 Sep; 372(4):847-854. PubMed ID: 17698078
[TBL] [Abstract][Full Text] [Related]
7. Structure-based identification of a new IAP-targeting compound that induces cancer cell death inducing NF-κB pathway.
Cossu F; Camelliti S; Lecis D; Sorrentino L; Majorini MT; Milani M; Mastrangelo E
Comput Struct Biotechnol J; 2021; 19():6366-6374. PubMed ID: 34938412
[TBL] [Abstract][Full Text] [Related]
8. Targeting the X-linked inhibitor of apoptosis protein through 4-substituted azabicyclo[5.3.0]alkane smac mimetics. Structure, activity, and recognition principles.
Mastrangelo E; Cossu F; Milani M; Sorrentino G; Lecis D; Delia D; Manzoni L; Drago C; Seneci P; Scolastico C; Rizzo V; Bolognesi M
J Mol Biol; 2008 Dec; 384(3):673-89. PubMed ID: 18851976
[TBL] [Abstract][Full Text] [Related]
9. Cleavage of human inhibitor of apoptosis protein XIAP results in fragments with distinct specificities for caspases.
Deveraux QL; Leo E; Stennicke HR; Welsh K; Salvesen GS; Reed JC
EMBO J; 1999 Oct; 18(19):5242-51. PubMed ID: 10508158
[TBL] [Abstract][Full Text] [Related]
10. TRAF2-binding BIR1 domain of c-IAP2/MALT1 fusion protein is essential for activation of NF-kappaB.
Garrison JB; Samuel T; Reed JC
Oncogene; 2009 Apr; 28(13):1584-93. PubMed ID: 19234489
[TBL] [Abstract][Full Text] [Related]
11. Solution structure and interaction with copper in vitro and in living cells of the first BIR domain of XIAP.
Hou MM; Polykretis P; Luchinat E; Wang X; Chen SN; Zuo HH; Yang Y; Chen JL; Ye Y; Li C; Banci L; Su XC
Sci Rep; 2017 Nov; 7(1):16630. PubMed ID: 29192194
[TBL] [Abstract][Full Text] [Related]
12. Optimization of benzodiazepinones as selective inhibitors of the X-linked inhibitor of apoptosis protein (XIAP) second baculovirus IAP repeat (BIR2) domain.
Kester RF; Donnell AF; Lou Y; Remiszewski SW; Lombardo LJ; Chen S; Le NT; Lo J; Moliterni JA; Han X; Hogg JH; Liang W; Michoud C; Rupert KC; Mischke S; Le K; Weisel M; Janson CA; Lukacs CM; Fretland AJ; Hong K; Polonskaia A; Gao L; Li S; Solis DS; Aguilar D; Tardell C; Dvorozniak M; Tannu S; Lee EC; Schutt AD; Goggin B
J Med Chem; 2013 Oct; 56(20):7788-803. PubMed ID: 24093940
[TBL] [Abstract][Full Text] [Related]
13. XIAP Interacts with and Regulates the Activity of FAF1.
Caballero-López MJ; Nieto-Díaz M; Yunta M; Reigada D; Muñoz-Galdeano T; Del Águila Á; Navarro-Ruíz R; Pita-Thomas W; Lindholm D; Maza RM
Biochim Biophys Acta Mol Cell Res; 2017 Jul; 1864(7):1335-1348. PubMed ID: 28414080
[TBL] [Abstract][Full Text] [Related]
14. Engineering ML-IAP to produce an extraordinarily potent caspase 9 inhibitor: implications for Smac-dependent anti-apoptotic activity of ML-IAP.
Vucic D; Franklin MC; Wallweber HJ; Das K; Eckelman BP; Shin H; Elliott LO; Kadkhodayan S; Deshayes K; Salvesen GS; Fairbrother WJ
Biochem J; 2005 Jan; 385(Pt 1):11-20. PubMed ID: 15485396
[TBL] [Abstract][Full Text] [Related]
15. Structure-based design and molecular profiling of Smac-mimetics selective for cellular IAPs.
Corti A; Milani M; Lecis D; Seneci P; de Rosa M; Mastrangelo E; Cossu F
FEBS J; 2018 Sep; 285(17):3286-3298. PubMed ID: 30055105
[TBL] [Abstract][Full Text] [Related]
16. IAP-antagonists exhibit non-redundant modes of action through differential DIAP1 binding.
Zachariou A; Tenev T; Goyal L; Agapite J; Steller H; Meier P
EMBO J; 2003 Dec; 22(24):6642-52. PubMed ID: 14657035
[TBL] [Abstract][Full Text] [Related]
17. Benzazepinones and benzoxazepinones as antagonists of inhibitor of apoptosis proteins (IAPs) selective for the second baculovirus IAP repeat (BIR2) domain.
Donnell AF; Michoud C; Rupert KC; Han X; Aguilar D; Frank KB; Fretland AJ; Gao L; Goggin B; Hogg JH; Hong K; Janson CA; Kester RF; Kong N; Le K; Li S; Liang W; Lombardo LJ; Lou Y; Lukacs CM; Mischke S; Moliterni JA; Polonskaia A; Schutt AD; Solis DS; Specian A; Taylor RT; Weisel M; Remiszewski SW
J Med Chem; 2013 Oct; 56(20):7772-87. PubMed ID: 24083782
[TBL] [Abstract][Full Text] [Related]
18. XIAP, a cellular member of the inhibitor of apoptosis protein family, links the receptors to TAB1-TAK1 in the BMP signaling pathway.
Yamaguchi K; Nagai S; Ninomiya-Tsuji J; Nishita M; Tamai K; Irie K; Ueno N; Nishida E; Shibuya H; Matsumoto K
EMBO J; 1999 Jan; 18(1):179-87. PubMed ID: 9878061
[TBL] [Abstract][Full Text] [Related]
19. NMR structure and mutagenesis of the inhibitor-of-apoptosis protein XIAP.
Sun C; Cai M; Gunasekera AH; Meadows RP; Wang H; Chen J; Zhang H; Wu W; Xu N; Ng SC; Fesik SW
Nature; 1999 Oct; 401(6755):818-22. PubMed ID: 10548111
[TBL] [Abstract][Full Text] [Related]
20. Protein-protein recognition as a first step towards the inhibition of XIAP and Survivin anti-apoptotic proteins.
Obiol-Pardo C; Granadino-Roldán JM; Rubio-Martinez J
J Mol Recognit; 2008; 21(3):190-204. PubMed ID: 18438971
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
